Gene study aims to predict stroke outcomes
NCT ID NCT07269288
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how changes in the GGCX gene relate to recovery after an ischemic stroke. Researchers will collect blood samples from 1,500 stroke patients and follow them for 12 months to track strokes, bleeding, and deaths. The goal is to understand if this gene can help predict who will have better or worse outcomes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors predict stroke outcomes and personalize treatment based on a patient's genes.
- What could go wrong
- This is an observational study, not a treatment trial. It may find no clear link between the GGCX gene and stroke prognosis, or results may not apply to all populations.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE ISCHEMIC STROKE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University Aerospace Center Hospital
Beijing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict stroke recovery?
- Can a drug boost brain recovery after stroke?
- Can a blood Clot's inflammation predict stroke recovery?
- Can a new infusion drug boost stroke recovery?
- Can removing clots from tiny brain arteries boost stroke recovery?
- Could vague stroke symptoms delay lifesaving treatment?